Search

everythinglearnresearchcommunity

for

Search:↓

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Carbamazepine, valproate, and clonazepam can cause mild to serious side effects during long-term epilepsy treatment.

pCLCA2 protein may help maintain skin structure and function.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

AH-001 could be a safer and more effective treatment for hair loss.

Clobetasol is more effective than metformin for treating localized alopecia areata.

The treatment was ineffective in humans.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Ciprofloxacin is slightly more effective than Clindamycin for reducing acne.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.